{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:37:58Z","timestamp":1751279878874},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10354-020-00736-3","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T09:02:50Z","timestamp":1582016570000},"page":"112-115","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of hypophosphatasia"],"prefix":"10.1007","volume":"170","author":[{"given":"Sebastian","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Resch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"issue":"11","key":"736_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11926-018-0778-5","volume":"20","author":"S Simon","year":"2018","unstructured":"Simon\u00a0S, Resch\u00a0H, Klaushofer\u00a0K, Roschger\u00a0P, Zwerina\u00a0J, Kocijan\u00a0R. Hypophosphatasia: from diagnosis to treatment. Curr Rheumatol Rep. 2018;20(11):69. https:\/\/doi.org\/10.1007\/s11926-018-0778-5.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"736_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11914-016-0309-0","volume":"14","author":"A Linglart","year":"2016","unstructured":"Linglart\u00a0A, Biosse-Duplan\u00a0M. Hypophosphatasia. Curr Osteoporos Rep. 2016;14(3):95\u2013105. https:\/\/doi.org\/10.1007\/s11914-016-0309-0.","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"736_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte\u00a0MP. Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233\u201346. https:\/\/doi.org\/10.1038\/nrendo.2016.14.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"736_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00247-018-4239-0","volume":"49","author":"AC Offiah","year":"2019","unstructured":"Offiah\u00a0AC, Vockley\u00a0J, Munns\u00a0CF, Murotsuki\u00a0J. Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives. Pediatr Radiol. 2019;49(1):3\u201322. https:\/\/doi.org\/10.1007\/s00247-018-4239-0.","journal-title":"Pediatr Radiol"},{"issue":"10","key":"736_CR5","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/jbmr.3226","volume":"32","author":"JR Shapiro","year":"2017","unstructured":"Shapiro\u00a0JR, Lewiecki\u00a0EM. Hypophosphatasia in adults: clinical assessment and treatment considerations. J\u00a0Bone Miner Res. 2017;32(10):1977\u201380. https:\/\/doi.org\/10.1002\/jbmr.3226.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"736_CR6","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00198-015-3346-0","volume":"27","author":"E Maman","year":"2016","unstructured":"Maman\u00a0E, Borderie\u00a0D, Roux\u00a0C, Briot\u00a0K. Absence of recognition of low alkaline phosphatase level in a\u00a0tertiary care hospital. Osteoporos Int. 2016;27(3):1251\u20134. https:\/\/doi.org\/10.1007\/s00198-015-3346-0.","journal-title":"Osteoporos Int"},{"key":"736_CR7","unstructured":"Ph.D. EM. http:\/\/www.sesep.uvsq.fr\/03_hypo_mutations.php. Accessed 22 Oct 2019."},{"issue":"Suppl 2","key":"736_CR8","first-page":"380","volume":"10","author":"C Rockman-Greenberg","year":"2013","unstructured":"Rockman-Greenberg\u00a0C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013;10(Suppl 2):380\u20138.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"9","key":"736_CR9","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt\u00a0T, Mussawy\u00a0H, Rolvien\u00a0T, Hawellek\u00a0T, Hubert\u00a0J, Ruther\u00a0W, et\u00a0al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017;28(9):2653\u201362. https:\/\/doi.org\/10.1007\/s00198-017-4087-z.","journal-title":"Osteoporos Int"},{"issue":"3","key":"736_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jbspin.2006.06.017","volume":"74","author":"HJ Girschick","year":"2007","unstructured":"Girschick\u00a0HJ, Haubitz\u00a0I, Hiort\u00a0O, Schneider\u00a0P. Long-term follow-up of bone mineral density in childhood hypophosphatasia. Joint Bone Spine. 2007;74(3):263\u20139. https:\/\/doi.org\/10.1016\/j.jbspin.2006.06.017.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"736_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12891-019-2420-8","volume":"20","author":"W Hogler","year":"2019","unstructured":"Hogler\u00a0W, Langman\u00a0C, Gomes da Silva\u00a0H, Fang\u00a0S, Linglart\u00a0A, Ozono\u00a0K, et\u00a0al. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a\u00a0longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019;20(1):80. https:\/\/doi.org\/10.1186\/s12891-019-2420-8.","journal-title":"BMC Musculoskelet Disord"},{"key":"736_CR12","unstructured":"Administration FaD. https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DrugInnovation\/ucm430302.htm. Accessed 22 Oct 2019."},{"issue":"1","key":"736_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"MP Whyte","year":"2016","unstructured":"Whyte\u00a0MP, Rockman-Greenberg\u00a0C, Ozono\u00a0K, Riese\u00a0R, Moseley\u00a0S, Melian\u00a0A, et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J\u00a0Clin Endocrinol Metab. 2016;101(1):334\u201342. https:\/\/doi.org\/10.1210\/jc.2015-3462.","journal-title":"J Clin Endocrinol Metab"},{"key":"736_CR14","volume-title":"Highlights of Prescribing Information","author":"Strensiq","year":"2016","unstructured":"Strensiq. Highlights of Prescribing Information. New Haven: Alexion Pharmaceuticals, Inc; 2016."},{"key":"736_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","volume":"121","author":"PS Kishnani","year":"2018","unstructured":"Kishnani\u00a0PS, Rockman-Greenberg\u00a0C, Rauch\u00a0F, Bhatti\u00a0MT, Moseley\u00a0S, Denker\u00a0AE, et al. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2018;121:149\u201362. https:\/\/doi.org\/10.1016\/j.bone.2018.12.011.","journal-title":"Bone"},{"issue":"10","key":"736_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte\u00a0MP, Greenberg\u00a0CR, Salman\u00a0NJ, Bober\u00a0MB, McAlister\u00a0WH, Wenkert\u00a0D, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N\u00a0Engl J Med. 2012;366(10):904\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1106173.","journal-title":"N Engl J Med"},{"issue":"2","key":"736_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte\u00a0MP, Simmons\u00a0JH, Moseley\u00a0S, Fujita\u00a0KP, Bishop\u00a0N, Salman\u00a0NJ, et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a\u00a0single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019;7(2):93\u2013105. https:\/\/doi.org\/10.1016\/S2213-8587(18)30307-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"736_CR18","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.2147\/DDDT.S154922","volume":"12","author":"SA Bowden","year":"2018","unstructured":"Bowden\u00a0SA, Foster\u00a0BL. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Drug Des Dev Ther. 2018;12:3147\u201361. https:\/\/doi.org\/10.2147\/DDDT.S154922.","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"736_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jbmr.3075","volume":"32","author":"MP Whyte","year":"2017","unstructured":"Whyte\u00a0MP. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J\u00a0Bone Miner Res. 2017;32(4):667\u201375. https:\/\/doi.org\/10.1002\/jbmr.3075.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"736_CR20","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte\u00a0MP. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J\u00a0Bone Miner Res. 2009;24(6):1132\u20134. https:\/\/doi.org\/10.1359\/jbmr.081253.","journal-title":"J Bone Miner Res"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-020-00736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-020-00736-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-020-00736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T15:00:53Z","timestamp":1613746853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-020-00736-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":20,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1007\/s10354-020-00736-3","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"19 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S. Simon declares that he has no competing interests. H. Resch receives a\u00a0research grant from ALEXION.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}